Ribonucleotide reductase
Assets acting on this target.
- Class
- Ribonucleotide reductase inhibitor (antimetabolite)
By indication
Related mechanisms
Ribonucleotide reductase drugs compared
3 drugs, stage by indication
| Drug | Developer | Modality | Furthest stage | Stage by indication |
|---|---|---|---|---|
| Hydroxyurea (Droxia) | Cheplapharm Arzneimittel GmbH, Waylis Therapeutics LLC | small molecule | Approved | Approved in Sickle Cell Disease |
| Hydroxyurea (Siklos)Siklos | Medunik USA, Theravia | small molecule | Approved | Approved in Sickle Cell Disease |
| Hydroxyurea (Xromi)Xromi | Nova Laboratories Limited, Rare Disease Therapeutics | small molecule | Approved | Approved in Sickle Cell Disease |